AI747448 inhibitors represent a specialized category of chemical compounds that are designed to target and modulate specific molecular pathways. These inhibitors are typically small molecules that interact with the AI747448 protein or enzyme, blocking its biological activity. The AI747448 protein could be a key component in various signaling pathways, such as those involved in regulating cellular growth, differentiation, or metabolic processes. By binding to the active site or an allosteric site of the target, these inhibitors disrupt the protein's natural function, leading to the alteration of downstream molecular interactions and the inhibition of biochemical processes associated with the protein's activity.
The design and development of AI747448 inhibitors involve extensive structural biology and chemical optimization studies. High-throughput screening techniques are often employed to identify lead compounds, which are then refined through structure-activity relationship (SAR) analyses. Crystallographic studies of the AI747448 protein, in conjunction with molecular modeling, allow scientists to determine the precise binding interactions between the inhibitors and the target. These interactions can be fine-tuned to increase the inhibitor's specificity and potency, often through modifications to functional groups that enhance binding affinity. Additionally, chemical properties such as solubility, stability, and metabolic profile are optimized to ensure the inhibitors can be effectively applied in various research settings, advancing our understanding of AI747448's role in fundamental biological systems.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Inhibits chloride channels indirectly by blocking the epithelial sodium channel, which in turn can decrease the intracellular sodium concentration leading to a reduced driving force for chloride to exit through chloride channel accessory 4B. | ||||||
Niflumic acid | 4394-00-7 | sc-204820 | 5 g | $32.00 | 3 | |
Inhibits various chloride channels through direct interaction with the channel pore, potentially inhibiting chloride channel accessory 4B by occluding its ion conduction pathway. | ||||||
Gallotannin | 1401-55-4 | sc-202619 sc-202619A sc-202619B sc-202619C sc-202619D sc-202619E sc-202619F | 1 g 10 g 100 g 250 g 1 kg 2.5 kg 5 kg | $26.00 $37.00 $67.00 $78.00 $234.00 $536.00 $983.00 | 12 | |
Acts as a non-specific channel blocker which may lead to the inhibition of chloride channel accessory 4B by binding to the channel or associated proteins. | ||||||
Flufenamic acid | 530-78-9 | sc-205699 sc-205699A sc-205699B sc-205699C | 10 g 50 g 100 g 250 g | $27.00 $79.00 $154.00 $309.00 | 1 | |
Known to inhibit chloride channels, potentially inhibiting chloride channel accessory 4B by altering its conformation or interaction with chloride ions. | ||||||
CFTR Inhibitor-172 | 307510-92-5 | sc-204680 sc-204680A | 10 mg 50 mg | $168.00 $520.00 | 10 | |
Specifically inhibits the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel and could inhibit chloride channel accessory 4B by a similar mechanism due to structural similarities. | ||||||
KRIBB11 | 342639-96-7 | sc-507391 | 5 mg | $95.00 | ||
Inhibits CFTR chloride channels, and could inhibit chloride channel accessory 4B by blocking the channel pore. | ||||||